Supreme Court temporarily extends mifepristone access

The Supreme Court has decided to leave women’s access to the abortion pill, mifepristone, untouched for now as they consider whether to impose restrictions on the drug. Justice Samuel Alito’s recent order allows women to continue obtaining the pill through pharmacies or mail without an in-person doctor visit, preventing restrictions imposed by a federal appeals court from taking effect.

This latest abortion controversy comes four years after the court’s conservative majority overturned Roe v. Wade, leading to several states effectively banning abortion. The current case originated from a lawsuit filed by Louisiana challenging the FDA’s rules on mifepristone prescription. The state argues that the policy undermines their ban on the drug and questions its safety, despite FDA scientists repeatedly deeming it safe and effective since its approval in 2000.

Mifepristone is commonly used in combination with misoprostol for medication abortions, which accounted for nearly two-thirds of all abortions in the U.S. in 2023. This dispute mirrors a previous case where lower courts sought to restrict access to mifepristone after Roe v. Wade was overturned. In that instance, the Supreme Court blocked the ruling, eventually dismissing the case.

Mainstream medical groups, the pharmaceutical industry, and Democratic lawmakers have cautioned against limiting access to mifepristone. Pharmaceutical companies warn that a ruling in favor of abortion opponents could disrupt the drug approval process. Despite FDA easing restrictions on mifepristone over the years, abortion opponents have continuously challenged its safety, filing petitions and lawsuits against the agency.

President Donald Trump’s administration has remained silent on the issue at the Supreme Court, despite federal regulations being at stake. The case puts the administration in a delicate position, given Trump’s reliance on anti-abortion groups for support while facing public opinion in favor of abortion rights.

Both sides interpreted the administration’s silence as an endorsement of the appellate ruling. Justice Alito, who authored the 2022 decision declaring abortion not a constitutional right, is overseeing the emergency appeals from Louisiana. The outcome of this case will have significant implications for women’s access to abortion medication and the ongoing debate surrounding reproductive rights.